首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1542978

全球筋膜切开术市场 - 2024-2031

Global Fasciotomy Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球筋膜切开术市场在2023年达到41.5亿美元，预计到2031年将达到66.8亿美元，在2024-2031年预测期间复合年增长率为6.3%。

筋膜切开术是一种外科手术，透过切开筋膜来缓解张力或压力，从而治疗由此导致的组织或肌肉区域的血液循环障碍。筋膜切开术是一种用于治疗急性筋膜室症候群的保肢手术。它有时也用于治疗慢性筋膜室压力症候群。此手术的成功率非常高，最常见的问题是附近神经的意外损伤。

在手术之前，医生会进行局部或全身麻醉。外科医生在受影响的肌肉室上方做一个切口，打开限制性筋膜（厚厚的结缔组织），以缓解压力并增加流向肌肉和神经的血液。如果多块肌肉受到影响，可能需要多个切口。

市场动态：

司机

骨筋膜室症候群盛行率增加

全球筋膜切开术市场的需求是由多种因素所驱动的。骨筋膜室症候群盛行率的上升推动了市场的成长。

此外，技术进步将推动治疗需求。例如，根据 nih.gov，急性骨筋膜室症候群的发生率估计为每 10 万人中 7.3 例，女性为每 10 万人中 0.7 例，其中大多数病例发生在创伤后。胫骨干骨折是急性筋膜室症候群最常见的原因，并且与 1% 至 10% 的急性筋膜室症候群发生率有关。

急性骨筋膜室症候群较常见于 35 岁以下的男性，这可能是由于骨筋膜室内肌肉量相对较大，且受高能创伤的可能性增加。有出血素质的患者，例如血友病，急性骨筋膜室症候群的风险更大。已有儿童白血病急性筋膜室症候群病例报告，但没有急性诱发性创伤。

限制

与程序相关的高成本以及批准新疗法的严格监管要求等因素预计将阻碍市场。

细分市场分析

全球筋膜切开术市场根据类型、应用、最终用户和地区进行细分。

分段植皮筋膜切开器材（STSG）约占全球筋膜切开市场占有率的58%

皮肤移植筋膜切开器材（STSG）领域预计将在预测期内占据最大的市场份额。在这一领域，政府监管的发展以及私人製造商研究资金的增加将推动该市场的发展。

例如，2021 年 4 月，美国食品药物管理局 (FDA) 向 Chemence Medical 重新设计的 Exofin 融合皮肤闭合系统授予 510(k) 批准。 Exofin fusion 提供自黏式柔性网带和快速固化的氰基丙烯酸 2-辛酯局部黏合剂，可覆盖和密封切口，同时也形成直接的微生物屏障以防止感染。

市场地理分析

北美约占全球筋膜切开市场占有率的42%

预计北美地区将在预测期内占据最大的市场份额。该地区骨筋膜室症候群发病率的上升、技术的进步以及人们意识的不断增强，有助于推动市场的发展。

例如，根据 clevelandclinic.org 报导，专家估计，美国每年每 10 万人中不到 10 人患有急性骨筋膜室症候群。然而，这种情况在患有某些类型骨折（骨折）的人中更为常见。例如，研究估计，大约 10% 的胫骨骨折患者会出现骨筋膜室症候群。

例如，2020 年 2 月，生物列印公司 T&R Biofab 宣布与强生医疗器材公司 Ethicon Llc., Inc. 达成新的合作协议。此次合作旨在开发用于伤口治疗、重建手术等的 3D 生物列印软组织支架。

Fasciotomy is a surgical procedure where the fascia is cut to relieve tension or pressure to treat the resulting loss of circulation to an area of tissue or muscle. Fasciotomy is a limb-saving procedure when used to treat acute compartment syndrome. It is also sometimes used to treat chronic compartment stress syndrome. The procedure has a very high rate of success, with the most common problem being accidental damage to a nearby nerve.

Before the procedure, doctors administer regional or general anesthesia. The surgeon makes an incision above the affected muscle compartment, opening the restrictive fascia-thick sheets of connective tissue-to relieve pressure and increase blood flow to muscles and nerves. More than one incision may be required if multiple muscles are affected.

Market Dynamics: Drivers

Increasing prevalence of compartment syndrome

The demand for the global fasciotomy market is driven by multiple factors. The rising prevalence of compartment syndrome propels the market growth.

Furthermore, the demand for treatment will be fueled by technological advancements. For instance, according to nih.gov, The incidence of acute compartment syndrome is estimated to be 7.3 per 100,000 in males and 0.7 per 100,000 in females, with the majority of cases occurring after trauma. Tibial shaft fracture is the most common cause of acute compartment syndrome and is associated with a 1 to 10 percent incidence of acute compartment syndrome.

Acute compartment syndrome occurs more commonly in males younger than 35, which may be due to a larger relative intracompartmental muscle mass and increased likelihood of being involved in high-energy trauma. Patients with bleeding diathesis, such as hemophilia, are at greater risk for acute compartment syndrome. Cases of acute compartment syndrome have been reported without acute precipitating trauma in pediatric leukemia.

Restraints

Factors such as high costs associated with the procedure and stringent regulatory requirements for the approval of new treatments are expected to hamper the market.

Market Segment Analysis

The global fasciotomy market is segmented based on type, application, end-user, and region.

The segment skin graft fasciotomy instrument (STSG) accounted for approximately 58% of the global fasciotomy market share

The skin graft fasciotomy instrument (STSG) segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and rising funds for private manufacturers for research would drive this market.

For instance, in April 2021, the US Food and Drug Administration (FDA) granted 510(k) approval to Chemence Medical's redesigned Exofin fusion skin closure system. Exofin fusion offers a self-adhering, flexible mesh strip and a rapidly curing 2-octyl cyanoacrylate topical adhesive, which covers and seals incisions while also creating an immediate microbial barrier to protect against infections.

Market Geographical Analysis

North America accounted for approximately 42% of the global fasciotomy market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of compartment syndrome, technological advancements, and growing awareness among people, in this region, help to propel the market.

For instance, according to clevelandclinic.org, experts estimate that fewer than 10 in every 100,000 people in the U.S. experience acute compartment syndrome each year. However, it's much more common in people who have some types of bone fractures (broken bones). For example, studies estimate that around 10% of people who break their tibia develop compartment syndrome.

For instance, in February 2020, Bioprinting company T&R Biofab announced a new collaboration agreement with Ethicon Llc., Inc., a Johnson & Johnson Medical Device Company. The partnership aims to develop a 3D bioprinted soft tissue scaffold for wound treatments, reconstructive surgery, and more.

Market Segmentation

By Instrument

Skin Graft Fasciotomy Instrument (STSG)
Negative Pressure Wound Treatment Fasciotomy Instrument (NPWT)
Vascular Ring Technique Fasciotomy Instrument
Continuous External Tissue Expansion Fasciotomy Instrument (CETE)
Others

By Application

Plantar Fasciitis
Acute Compartment Syndrome
Chronic Compartment Syndrome
Others

By End-User

Hospitals
Specialty Clinics
Ambulatory and Surgery Centers
Others

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Market Competitive Landscape

The major global players in the global fasciotomy market include Zipline Medical Inc., Stryker Corporation, DermaClose, Terumo Corporation, Merit Medical Systems, Ethicon Llc., Cardinal Health, 3M, Biopro Inc., and Southmedic Inc. among others.

Key Developments

In June 2022, Advanced Medical Solutions, a specialist in tissue-healing technologies, received FDA 510(k) approval for LiquiBand XL, a new device that can close longer wounds. The device consists of a surgical mesh which is used to close the wound and LiquiBand glue which is used to strengthen the closure and prevent infection.
In May 2024, SouthMedic, a leading manufacturer of surgical blades, scalpels, and innovative medical devices, announced its partnership with Nano Surgical to become the exclusive master distributor of Lumohs MD no. 3 Lighted Scalpel Handles in Canada.

Why Purchase the Report?

To visualize the global fasciotomy market segmentation based on type, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global fasciotomy market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.

The global fasciotomy market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Compartment Syndrome
  - 4.1.1.2. Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Procedure
  - 4.1.2.2. Stringent Regulatory Requirements
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Skin Graft Fasciotomy Instrument*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Negative Pressure Wound Treatment Fasciotomy Instrument
6.4. Vascular Ring Technique Fasciotomy Instrument
6.5. Continuous External Tissue Expansion Fasciotomy Instrument
6.6. Vistide
6.7. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Plantar Fascitis*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Acute Compartment Syndrome
7.4. Chronic Compartment Syndrome
7.5. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory and Surgery Centers
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Zipline Medical Inc. *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Stryker Corporation
11.3. DermaClose
11.4. Terumo Corporation
11.5. Merit Medical Systems
11.6. Ethicon Llc.
11.7. Cardinal Health
11.8. 3M
11.9. Biopro Inc.
11.10. Southmedic Inc. (*LIST NOT EXHAUSTIVE)